Cargando…

Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients

Carboxylesterase 1 (CES1) hydrolyzes the prodrug clopidogrel to an inactive carboxylic acid metabolite. The effects of CES1 S75N (rs2307240,C>T) on clopidogrel response among 851 acute coronary syndrome patients who came from the north, central and south of China were studied. The occurrence rati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Fei-Yan, Luo, Jian-Quan, Liu, Min, Chen, Bi-Lian, Cao, Shan, Liu, Zhao-Qian, Zhou, Hong-Hao, Zhou, Gan, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543069/ https://www.ncbi.nlm.nih.gov/pubmed/28775293 http://dx.doi.org/10.1038/s41598-017-07736-1

Ejemplares similares

The Herb-Drug Interaction of Clopidogrel and Xuesaitong Dispersible Tablet by Modulation of the Pharmacodynamics and Liver Carboxylesterase 1A Metabolism
por: Ma, Shitang, et al.
Publicado: (2018)

Carboxylesterases in lipid metabolism: from mouse to human
por: Lian, Jihong, et al.
Publicado: (2017)

miR-6076 rs1463411 polymorphisms are associated with bleeding during clopidogrel treatment in patients with acute coronary syndrome
por: Mo, Zhen-Zhen, et al.
Publicado: (2023)

Determinants to optimize response to clopidogrel in acute coronary syndrome
por: Giusti, Betti, et al.
Publicado: (2010)

Annotation and expression of carboxylesterases in the silkworm, Bombyx mori
por: Yu, Quan-You, et al.
Publicado: (2009)

Effects of switching ticagrelor to clopidogrel on cardiovascular outcomes in patients with acute coronary syndrome
por: Liu, Lin, et al.
Publicado: (2018)

Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study
por: Yao, Ying, et al.
Publicado: (2019)

Carboxylesterase1/Esterase-x Regulates Chylomicron Production in Mice
por: Quiroga, Ariel D., et al.
Publicado: (2012)

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Norgard, Nicholas B, et al.
Publicado: (2009)

Purification, Characterization, and Sensitivity to Pesticides of Carboxylesterase From Dendrolimus superans (Lepidoptera: Lasiocampidae)
por: Zou, Chuan-shan, et al.
Publicado: (2014)

Association of CYP2C19 Polymorphism with Clopidogrel Resistance in Patients with Acute Coronary Syndrome in China
por: Su, Qiang, et al.
Publicado: (2019)

Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma
por: Goeppert, Benjamin, et al.
Publicado: (2019)

The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics
por: Di, Li
Publicado: (2018)

Human carboxylesterases: a comprehensive review
por: Wang, Dandan, et al.
Publicado: (2018)

Small-molecule inhibitors of carboxylesterase Notum
por: Zhao, Yuguang, et al.
Publicado: (2021)

Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes
por: He, Peixun, et al.
Publicado: (2021)

Comparison of ticagrelor with clopidogrel on quality of life in patients with acute coronary syndrome
por: Moon, Hyeyeon, et al.
Publicado: (2021)

New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirin
por: Liu, Xiaomin, et al.
Publicado: (2021)

The Functional Characterization of Carboxylesterases Involved in the Degradation of Volatile Esters Produced in Strawberry Fruits
por: Zhang, Lingjie, et al.
Publicado: (2022)

Functional Analyses of House Fly Carboxylesterases Involved in Insecticide Resistance
por: Feng, Xuechun, et al.
Publicado: (2020)

An Examination of Clopidogrel in the Treatment of Coronary Microvascular Disease
por: Iskandar, Nicholas P, et al.
Publicado: (2022)

Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1
por: Xu, Minqin, et al.
Publicado: (2023)

Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
por: Grima, Daniel T, et al.
Publicado: (2014)

2220: Pharmacogenomic determinants in Caribbean Hispanics of clopidogrel failure in acute coronary syndrome
por: Melin, Kyle, et al.
Publicado: (2018)

Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2023)

Inhibition of human carboxylesterases by ginsenosides: structure–activity relationships and inhibitory mechanism
por: Sun, Zhao-Hui, et al.
Publicado: (2019)

Ticagrelor versus Clopidogrel in Patients with Severe Renal Insufficiency Undergoing PCI for Acute Coronary Syndrome
por: Chen, Yunxian, et al.
Publicado: (2022)

The roles of carboxylesterase and CYP isozymes on the in vitro metabolism of T-2 toxin
por: Lin, Ni-Ni, et al.
Publicado: (2015)

Clopidogrel resistance response in patients with coronary artery disease and metabolic syndrome: the role of hyperglycemia and obesity
por: Wu, Zhao-Ke, et al.
Publicado: (2015)

Detoxification of Fumonisins by Three Novel Transaminases with Diverse Enzymatic Characteristics Coupled with Carboxylesterase
por: Wang, Yue, et al.
Publicado: (2023)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
por: YANG, Bin, et al.
Publicado: (2018)

Carboxylesterase-Cleavable Biotinylated Nanoparticle for Tumor-Dual Targeted Imaging
por: Chen, Peiyao, et al.
Publicado: (2019)

Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI)
por: Chen, Shuxia, et al.
Publicado: (2017)

Discovery of triterpenoids as potent dual inhibitors of pancreatic lipase and human carboxylesterase 1
por: Zhang, Jing, et al.
Publicado: (2022)

A Review of Danshen Combined with Clopidogrel in the Treatment of Coronary Heart Disease
por: Zhang, Zhaojian, et al.
Publicado: (2019)

Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
por: Zheng, Wei, et al.
Publicado: (2019)

Carboxylesterase 1 family knockout alters drug disposition and lipid metabolism
por: Gan, Changpei, et al.
Publicado: (2023)

Simultaneous determination of clopidogrel, 2-oxo-clopidogrel, and the thiol metabolite of clopidogrel in human plasma by LC-MS/MS
por: Xu, Lei, et al.
Publicado: (2022)

Clinical, Pharmacokinetic, and Pharmacogenetic Determinants of Clopidogrel Resistance in Korean Patients with Acute Coronary Syndrome
por: Park, Kyoung-Jin, et al.
Publicado: (2011)

Quality of life (QOL) evaluation after acute coronary syndrome with simultaneous clopidogrel treatment
por: Chudek, Jerzy, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ja5o0ipb97ea9iremh3cm68pqq